Semaglutide (Wegovy/Ozempic, Novo Nordisk) and liraglutide (Saxenda, Novo Nordisk) made up 31.4% and 35.3% of all new GLP-1 receptor agonist prescriptions in 2019, respectively
Prime IV Hydration & Wellness also has power IV solutions that offer a concentrated infusion that dramatically reduces your appointment time by fifteen to twenty-five minutes
COA accession: 2603130115
Users guide to mechanism of action and clinical use of GLP-1 receptor agonists
Ipamorelin Ipamorelin is a GHS (Growth Hormone Secretagogue) in the form of a synthesized peptide, which means it stimulates the production of GH
Depth of evidence is where tesamorelin stands apart: it carries multiple randomized controlled trials and an FDA approval, whereas ipamorelin remains a research compound with primarily preclinical data, and sermorelin sits between them with older clinical history